Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06000410 | A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee | PHASE3 | COMPLETED | 594 | — | — | Sep 1, 2023 | Nov 1, 2025 | Dec 22, 2025 | - | — |
| NCT04636229 | Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee | PHASE3 | COMPLETED | 516 | — | — | Dec 1, 2020 | Aug 1, 2025 | Oct 15, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| Amniotic Suspension Allograft | BIOLOGICAL | This investigational product is a cryopreserved product derived from human amnion and cells from the amniotic fluid. |
| Placebo | DRUG | Matching placebo is 0.9% normal saline: 4 mL to be injected IA. |